Evidence map›Paper›PMID 33828395›Full record

ArticleWorld journal of gastroenterology2021

Risk perception and knowledge of COVID-19 in patients with celiac disease.

Jamie Zhen, Juan Pablo Stefanolo, María de la Paz Temprano, Caroline L Seiler, Alberto Caminero, Enrique de-Madaria, Miguel Montoro Huguet, Vivas Santiago, Sonia Isabel Niveloni, Edgardo Gustavo Smecuol and 15 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Cessation of Face Mask Use after COVID-19 Vaccination in Patients with Diabetes: Prevalence and Determinants.International journal of environmental research and public health · 2023
    Article
  5. COVID-19 and celiac disease: a review.Therapeutic advances in gastroenterology · 2023
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 1 institution in 1 country.

Jamie ZhenDepartment of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University Medical Center, Hamilton Health Sciences, Hamilton L8S4K1, ON, Canada.
Juan Pablo StefanoloDepartment of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
María de la Paz TempranoDepartment of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
Caroline L SeilerDepartment of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University Medical Center, Hamilton Health Sciences, Hamilton L8S4K1, ON, Canada.
Alberto CamineroDepartment of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University Medical Center, Hamilton Health Sciences, Hamilton L8S4K1, ON, Canada.
Enrique de-MadariaDepartment of Pancreatic Unit, Hospital General Universitario de Alicante, Alicante 03010, Spain.
Miguel Montoro HuguetDepartment of Medicine, Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza 50009, Spain.
Vivas SantiagoDepartment of Gastroenterology, Univ Hosp Leon, Gastroenterol Unit, Altos de Nava S-N, Leon 24071, Spain.
Sonia Isabel NiveloniDepartment of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
Edgardo Gustavo SmecuolDepartment of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
Luis Uzcanga DominguezDepartment of Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico DF 14080, Mexico.
Elena TruccoDepartment of Medicine, Universidad de la Republic, Montevideo 11800, Uruguay.
Virginia LopezDepartment of Medicine, Universidad de la Republic, Montevideo 11800, Uruguay.
Carolina OlanoDepartment of Medicine, Universidad de la Republic, Montevideo 11800, Uruguay.
Pasquale MansuetoDepartment of Internal Medicine, PROMISE Department, University of Palermo, Palermo 90127, Italy.
Antonio CarroccioDepartment of Internal Medicine, V. Cervello Hospital, PROMISE Department, University of Palermo, Palermo 90127, Italy.
Peter H GreenCeliac Disease Center, Columbia University Medical Center, Columbia Univ, Celiac Dis Ctr, Div Digest and Liver Dis, New York, NY 10032, United States.
Donald DuerksenDepartment of Medicine, St Boniface Gen Hosp, University of Manitoba, Winnipeg R2H 2A6, Canada.
Andrew S DayDepartment of Paediatrics, University of Otago Christchurch, Christchurch 8041, New Zealand.
Jason A Tye-DinDepartment of Gastroenterology, Royal Melbourne Hospital, Immunology Division, Walter and Eliza Hall Institute, Melbourne 3052, Australia.
Julio César BaiDepartment of Medicine, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires 1264, Argentina.
Carolina CiacciDepartment of Medicine, Surgery and Dentry, Scuola Medica Salernitana, University of Salerno, Celiac Center at the University Hospital San Giovanni di Dio e Ruggi di Aragona, Salerno 84131, Italy.
Elena F VerdúDepartment of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton L8S4K1, ON, Canada.
Benjamin LebwohlThe Celiac Disease Center, Columbia University, New York, NY 10032, United States.
M Ines Pinto-SanchezDepartment of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton L8S4K1, ON, Canada. pintosm@mcmaster.ca.
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe recently demonstrated that the odds of contracting coronavirus disease 2019 (COVID-19) in patients with celiac disease (CeD) is similar to that of the general population. However, how patients with CeD perceive their COVID-19 risk may differ from their actual risk.

aimTo investigate risk perceptions of contracting COVID-19 in patients with CeD and determine the factors that may influence their perception.

methodsWe distributed a survey throughout 10 countries between March and June 2020 and collected data on demographics, diet, COVID-19 testing, and risk perceptions of COVID-19 in patients with CeD. Participants were recruited through various celiac associations, clinic visits, and social media. Risk perception was assessed by asking individuals whether they believe patients with CeD are at an increased risk of contracting COVID-19 when compared to the general population. Logistic regression was used to determine the influencing factors associated with COVID-19 risk perception, such as age, sex, adherence to a gluten-free diet (GFD), and comorbidities such as cardiac conditions, respiratory conditions, and diabetes. Data was presented as adjusted odds ratios (aORs).

resultsA total of 10737 participants with CeD completed the survey. From them, 6019 (56.1%) patients with CeD perceived they were at a higher risk or were unsure if they were at a higher risk of contracting COVID-19 compared to the non-CeD population. A greater proportion of patients with CeD perceived an increased risk of contracting COVID-19 when compared to infections in general due to their CeD (56.1%

conclusionOverall, high levels of risk perceptions, such as those found in patients with CeD, may increase an individual's pandemic-related stress and contribute to negative mental health consequences. Therefore, it is encouraged that public health officials maintain consistent communication with the public and healthcare providers with the celiac community. Future studies specifically evaluating mental health in CeD could help determine the consequences of increased risk perceptions in this population.

Indexed as

Celiac DiseaseCOVID-19AgedCOVID-19 TestingHumansMalePerceptionSARS-CoV-2Celiac diseaseCoronavirusCOVID-19GlutenInfectionKnowledgePerceptionRisk

Identifiers

PMID33828395
PMCPMC8006100
OpenAlexW3143895974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.